A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...
Multi-frequency-region parallel sensing (MFRPS) is poised to enable larger-sized, thinner, and more responsive touchscreens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback